Ian Lewis
- Epidemiology top 5%
- Endocrinology, Diabetes and Metabolism top 1%
- Molecular Biology
- Oncology top 10%
- Neurology top 5%
- Co-authors
- Christian BrunsGisbert WeckbeckerU. BrinerGuy Meno‐TetangRainer AlbertDaniël HoyerHerbert SchmidJanos Pless
- Topics
- Neuroendocrine Tumor Research Advances (11 papers)Chemical Synthesis and Analysis (9 papers)Pituitary Gland Disorders and Treatments (8 papers)
- Journals
- Angewandte Chemie International EditionThe Journal of Clinical Endocrinology & MetabolismNature Reviews Drug Discovery
- Partner nations
- SwitzerlandUnited StatesNetherlands
In The Last Decade
Ian Lewis
25 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Epidemiology 922
- Endocrinology, Diabetes and Metabolism 794
- Molecular Biology 566
- Oncology 397
- Neurology 340
Countries citing papers authored by Ian Lewis
This map shows the geographic impact of Ian Lewis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Lewis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Lewis more than expected).
Fields of papers citing papers by Ian Lewis
This network shows the impact of papers produced by Ian Lewis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Lewis. The network helps show where Ian Lewis may publish in the future.
Co-authorship network of co-authors of Ian Lewis
This figure shows the co-authorship network connecting the top 25 collaborators of Ian Lewis. A scholar is included among the top collaborators of Ian Lewis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Lewis. Ian Lewis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 22 | |
| 2 | 33 | |
| 3 | 7 | |
| 4 | 22 | |
| 5 | 17 | |
| 6 | 49 | |
| 7 | 4 | |
| 8 | 16 | |
| 9 | 7 | |
| 10 | 44 | |
| 11 | 12 | |
| 12 | 46 | |
| 13 | Medicinal chemistry of somatostatin analogs leading to the DTPA and DOTA conjugates of the multi-receptor-ligand SOM230. | 6 |
| 14 | 1 | |
| 15 | 117 | |
| 16 | 69 | |
| 17 | 444 | |
| 18 | 91 | |
| 19 | SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profilebreakdown → | 555 |
| 20 | 18 |
About Ian Lewis
Ian Lewis is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmaceutical Science and Epidemiology, having authored 26 papers that have together received 1.9k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (11 papers), Chemical Synthesis and Analysis (9 papers) and Pituitary Gland Disorders and Treatments (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (794 citations), Epidemiology (922 citations) and Neurology (340 citations). Ian Lewis has collaborated with scholars based in Switzerland, United States and Netherlands. Frequent co-authors include Christian Bruns, Gisbert Weckbecker, U. Briner, Guy Meno‐Tetang, Rainer Albert, Daniël Hoyer, Herbert Schmid, Janos Pless, W. Bauer and Nagarajan Chandramouli. Their work appears in journals such as Angewandte Chemie International Edition, The Journal of Clinical Endocrinology & Metabolism and Nature Reviews Drug Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.